, 5 , 181, doi: Lu, S
de Garca Oteyza G, Garca-Albisua AM
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite and body weight, while tesamorelin is a growth hormone-releasing hormone analogue that stimulates pituitary GH release to reduce visceral fat, primarily in HIV-positive patients with lipodystrophy
Semalix 3 Tablet 10's is used in the treatment of Type 2 diabetes mellitus in adults
The FDA has issued warnings regarding certain compounded semaglutide and tirzepatide products, citing concerns related to purity, dosing accuracy, and contamination
Choosing between the two depends on individual treatment goals , tolerability , and accessibility